• No results found

Basic and clinical aspects of mucosal inflammation and healing in Crohn's disease

N/A
N/A
Protected

Academic year: 2021

Share "Basic and clinical aspects of mucosal inflammation and healing in Crohn's disease"

Copied!
2
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

Basic and clinical aspects of mucosal inflammation and healing in

Crohn's disease

Gao, Q

Citation

Gao, Q. (2005, February 1). Basic and clinical aspects of mucosal inflammation and healing

in Crohn's disease. Retrieved from https://hdl.handle.net/1887/850

Version: Corrected Publisher’s Version

License: Licence agreement concerning inclusion of doctoral thesis in theInstitutional Repository of the University of Leiden Downloaded from: https://hdl.handle.net/1887/850

(2)

Statements

with the thesis

Basic and Clinical Aspects of Mucosal Inflammation and Healing in Crohn's Disease

1. Basic fibroblast growth factor, in concert with tumor necrosis factor-α, plays a role in the inflammation and tissue repair process in Crohn's disease patients with a fistulizing disease phenotype. (This thesis)

2. Matrix metalloproteinase-2 participates in the stromal processes, whereas matrix metalloproteinase-9 is predominantly associated with the leucocyte-mediated inflammatory process in the intestinal mucosa of patients with inflammatory bowel disease. (This thesis)

3. The basis of the anti-inflammatory and immunodulatory efficacy of infliximab in Crohn's disease is not by directly affecting the TNF-α producing cells. (This thesis) 4. The serum matrix metalloproteinase-2 and matrix metalloproteinase-9 level in Crohn's

disease patients display an inverse changing pattern, i.e. an increase of matrix metalloproteinase-2 and a decrease of matrix metalloproteinase-9, during the treatment with infliximab, although not strictly related to the clinical effect of infliximab. (This thesis)

5. The enhanced leucocyte matrix metalloproteinase-9 expression in Crohn's disease seems to be regulated by and responsive to tumor necrosis factor-α mediation. (This thesis)

6. There is ample evidence that implicate genetic susceptibility, immune abnormalities and the lumenal microflora as contributors to the aetio-pathophysiology of inflammatory bowel disease.

7. Nowadays, infliximab is an important treatment option for patients with moderately to severely active and/or fistulizing Crohn's disease.

8. Matrix metalloproteinase activity is not only relevant to acute tissue injury but also related to matrix modelling, angiogenesis, and healing.

9. Increased tumor necrosis factor-α expression in the intestinal mucosa rather than in serum of Crohn's disease patients is of importance to the inflammatory process.

10. A journey of a thousand miles begins with a single step. 11. Learning is a treasure that will follow its owner everywhere.

12. To Chinese people, Holland stands for windmills, wooden shoes and tulips, as well as Heineken and Philips. However, most of them do not expect that there is a great similarity between these two countries: almost everyone owns and rides a bike.

Qiang Gao

Referenties

GERELATEERDE DOCUMENTEN

The experiments described in this thesis were performed at the Department of Gastroenterology and Hepatology, Leiden University M edical Center, The Netherlands (Head: Prof.. I am

Genezing van de fistelende-perianale vorm van CD wordt weerspiegeld door een daling van de verhoogde bFGF spiegel in het serum, met name samenhangend met behandeling middels

In inflammatory cells and granulation tissue a high level of bFGF protein and mRNA indicates that bFGF not only participates in tissue repair and wound healing, but

Patients and Methods: CD patients with fistulizing (n=10) or active disease (n=7) were administered infliximab and evaluated for serum levels of the MMPs and clinical

Aim: Assessment of the expression of matrix metalloproteinases (MMP)-2 and MMP-9 and their mRNA in intestinal tissue of patients with inflammatory bowel disease (IBD),

Control group: Blood samples without LPS stimulation were incubated with 0.9% NaCl, at an equal volume to LPS and/or infliximab solutions under the same

This preliminary study revealed that the healing of fistulas in CD by treatment with infliximab is accompanied by a decrease in serum bFGF levels, whereas the

ÍΟÏ0ÐÑÒÓÒÔ Ð ÕÖ®×AؼÙÐ Ú]Ú!ÖÚ]Ð ÖpÛÛÖ®Ü0ØÝÞ]ÕÒßUßÒÔ ÖàØÑÔ áâÕÐ Öã Öä0ÙØ ÙÖpâUÒßßÒdä–Ü0å æ ÕçÐ èÐ éGÒÓêÖëBÕâÞ!ìpáã ÒÔ Þ!íÓÒíÐ ÚmîÓâÖÓã ÒíÔOìâÖëBÔ ï ð